AIFF - FIREFLY NEUROSCIENCE, INC.


2.18
-0.840   -38.532%

Share volume: 7,120,917
Last Updated: 03-27-2026
Computer Software/Services – Computer Programming And Data Processing: 0.14%

PREVIOUS CLOSE
CHG
CHG%

$3.02
-0.84
-0.28%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
45%
Profitability 35%
Dept financing 38%
Liquidity 70%
Performance 50%
Company vs Stock growth
vs
Performance
5 Days
15.96%
1 Month
207.04%
3 Months
134.51%
6 Months
-24.83%
1 Year
-46.96%
2 Year
-36.99%
Key data
Stock price
$2.18
P/E Ratio 
0.00
DAY RANGE
$2.16 - $2.66
EPS 
-$2.69
52 WEEK RANGE
$0.62 - $4.51
52 WEEK CHANGE
-$44.53
MARKET CAP 
38.973 M
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-21-2025
BETA 
4.90
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$17,852,302
AVERAGE 30 VOLUME 
$27,999,462
Company detail
CEO: Jon Olsen
Region: US
Website: fireflyneuro.com
Employees: 0
IPO year: 2007
Issue type: Common Stock
Market: XNAS
Industry: Computer Software/Services – Computer Programming And Data Processing
Sector: Services

Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.

Recent news